Table 1.

Baseline demographic and clinical characteristics of COVID-19 patients with and without pulmonary sarcoidosis before and after propensity score matching.

	Before propensity matching					After propensity matching
	Sarcoidosis cohort (n = 954)		Non-sarcoidosis cohort (n = 277317)		p-value/SDiff	Sarcoidosis cohort (n = 954)		Non-sarcoidosis cohort (n = 954)		p-value/SDiff
Variable	Number/Mean	Percent/SD	Number	Percent/SD		Number/Mean	Percent/SD	Number	Percent/SD
Demographics
Age (Mean)	56.3	13.2	45.8	19	<0.001/0.64	56.3	13.2	57.4	14.9	0.11/0.07
Male	333	34.91	123793	44.64	<0.001/0.20	333	34.91	322	33.75	0.59/0.02
Female	619	64.89	152513	54.99	<0.001/0.20	619	64.89	632	6.25	0.53/0.03
BMI (30 and above)	310	32.50	41049	14.80	<0.001/0.42	310	32.50	315	33.02	0.81/0.01
Black or African American	474	49.69	53122	19.16	<0.001/0.68	474	49.68	475	49.79	0.96/0.002
White	410	42.98	157160	56.67	<0.001/0.28	410	42.98	405	42.45	0.82/0.01
Hispanic or Latino	58	6.08	44958	16.21	<0.001/0.32	58	6.08	66	6.91	0.45/0.03
Comorbidities
Hypertension	639	66.98	72443	26.12	<0.001/0.89	639	66.98	650	68.13	0.59/0.02
Chronic lower respiratory diseases	467	48.95	39927	14.39	<0.001/0.8	467	48.95	466	48.85	0.96/0.002
Diabetes mellitus	368	38.57	37447	13.50	<0.001/0.59	368	38.57	348	36.48	0.34/0.04
Ischemic heart disease	261	27.35	21228	7.66	<0.001/0.54	261	27.36	252	26.42	0.64/0.02
Nicotine dependence	135	14.15	17943	6.47	<0.001/0.25	135	14.15	130	13.63	0.74/0.02
Chronic kidney disease	184	19.28	16125	5.82	<0.001/0.42	184	19.29	170	17.82	0.41/0.04

Table Legend: Abbreviation: BMI: Body Mass Index; SDiff: Standard Difference; SD: Standard Deviation.